HOLEN SIE SICH 10% RABATT BEI DER ANMELDUNG
QUALITÄTSTESTS ÜBERPRÜFEN
SENDE UNS EMAIL
Peptid-Wissensdatenbank
Wir veröffentlichen Artikel über die Verwendung von Peptiden in der Medizin, Nahrungsergänzung und deren Auswirkungen auf Gesundheit und Schönheit.
Mehr lesen

Blog

The number of PubMed publications on synthetic peptides grows by several to more than ten percent each year. BPC-157 pentadecapeptide, Thymosin Beta-4 fragments, GLP-1 receptor agonists, and nootropic peptides from the Russian pharmacology school ? each of these directions has its own literature, research models, and methodological limitations. This blog organizes that knowledge by category.

Who is this blog for? For people evaluating peptides through analysis of available literature. For academic researchers, biohackers, lifestyle medicine physicians, and pharmacists looking for references to support patient discussions.

bam-15 training in a capsule, fat burner
BAM-15 — what does the research say about the mitochondrial uncoupler as an anti-obesity candidate?

BAM-15 is a relatively new compound in energy-metabolism research. Metabolic pharmacology has a long and disturbing history with mitochondrial uncouplers. 2,4-dinitrophenol (DNP) was used as a weight-loss drug in the 1930s — and has left a legacy of deaths from hyperthermia, cataracts, and multiple organ failure. The Food and Drug Administration has withdrawn DNP from the market […]

Mehr lesen
A woman meditates to maintain her health and longevity
NMN (Nicotinamide Mononucleotide) – what research says about NAD+, aging and supplementation

NMN has been the star of longevity supplementation for the last five years. It appears on David Sinclair’s podcasts, in biohacker protocols, and on premium drugstore shelves. Marketing easily exceeds science here – and at the same time, some laboratory observations on NMN and NAD+ are so thoroughly documented that they cannot be ignored. This article clears up the picture: what exactly is […]

Mehr lesen
Semaglutide + Cagrilintide 2 mg + 2 mg PEN
CagriSema – a combination of semaglutide and cagrilintide in clinical trials for obesity

The evolution of the pharmacology of obesity treatment in the last decade has been in the sequence of “adding receptors” – from a GLP-1 monoagonist (semaglutide → Ozempic, Wegovy), through a GLP-1 + GIP agonist (tirzepatide → Mounjaro, Zepbound), to a GLP-1 + GIP + glucagon triagonist (retatrutide in phase III). CagriSema adds a separate signaling pathway to this narrative – amylin – that is still not […]

Mehr lesen
The medic shows a capsule containing tesofensin
Tesofensine — what does the research say about a neurotransmitter-acting anorectic?

Most of today’s high-profile weight-loss molecules – semaglutide, tirzepatide, retatrutide – act on the incretin axis. It affects one specific biochemical pathway: GLP-1 (and related) receptors. Tesofensine represents a completely different pharmacological route: it inhibits the reuptake of three neurotransmitters at the same time – dopamine, norepinephrine and serotonin. A mechanism more similar to classic psychostimulants, but in a new generation version with a different […]

Mehr lesen
GHK-Cu in cosmetics – what skin research says

GHK-Cu is the skincare star of recent years. It appears in descriptions of premium serums, in dermatologists’ educational materials on Instagram and in beauty blogs under the slogans “copper tripeptide changes the skin”. Marketing easily exceeds science here – and vice versa: reliable data is sometimes hidden under a layer of promises in which it is difficult to distinguish what has been demonstrated in the laboratory from what […]

Mehr lesen
Slim woman holding doughnuts, illustrative image for tirzepatide metabolism research
Tirzepatide – dual GIP/GLP-1 agonist in metabolism studies

Tirzepatide has two distinct regulatory statuses, which this article keeps separate from the first sentence to the last: as an approved medicinal product – Mounjaro (type 2 diabetes, FDA and EMA approval in 2022) and Zepbound (obesity, FDA approval 2023, EMA 2024). In this status, tirzepatide has dosing protocols in clinical settings, prescription availability, and […]

Mehr lesen
HPLC vs. MS: A Comparison of Peptide Analysis Methods
HPLC vs MS – methods for analyzing the purity of research peptides

In a laboratory working with peptides, there comes a moment when the supplier sends a certificate of analysis with two key data: an HPLC chromatogram with the declaration “purity ≥98%” and a mass spectrum with the molecular mass consistent with the theoretical value. To a person without a background in analytical chemistry, both documents look like a technical formality – a strip of peaks, a few numbers, the signature of a QC employee. […]

Mehr lesen
semax vs selank nootropic peptides
Nootropic peptides – Semax vs Selank in scientific studies

In the 1970s and 1980s, the Russian school of peptidology developed in parallel with—and often independently of—mainstream Western neuropharmacology. Research teams at the Institute of Molecular Genetics of the Russian Academy of Sciences and the Institute of Experimental Pharmacology in Moscow worked on a strategy that would only begin to be explored in Western pharmacology a decade later: take short, biologically […]

Mehr lesen
image with the word “oxytocin”
Oxytocin – the trust peptide in neuroscience

In 1953, the American biochemist Vincent du Vigneaud from Cornell University published a paper in the Journal of the American Chemical Society that won him the Nobel Prize in Chemistry two years later. Du Vigneaud chemically synthesized the first hormonal peptide, oxytocin. Success was not a minor laboratory achievement; this was historical validation of the concept that small peptide molecules could […]

Mehr lesen
image with the word “metabolism”
GLP-1, GIP, glucagon – how do incretins work in regulating metabolism

GLP-1, GIP, glucagon – how do incretins work in regulating metabolism In 1964, two research teams independently observed a phenomenon that at first glance seemed to be a measurement anomaly. Glucose given orally to a healthy person caused a much greater insulin release than the same dose of glucose given intravenously – at the same blood glucose level. The difference is not […]

Mehr lesen
semaglutide vs retatrutide
Semaglutide vs Retatrutide – comparison of mechanisms and clinical outcomes

Two peptides from the same broad pharmacological class – incretin agonists – but two completely different molecule design philosophies. Semaglutide, developed by Denmark’s Novo Nordisk and launched in 2017, is a GLP-1 receptor monoagonist – a continuation of the lineage previously started by liraglutide, exenatide and lixisenatide. The design assumption was conservative: take a proven mechanism (activation of one […]

Mehr lesen
peptide calculator in laboratory
Peptide calculator – how to calculate the concentration and volume of the working solution

The peptide calculator helps you avoid mistakes when working with research peptides. The most common error is not a reconstitution error or a storage error. The most common error is an arithmetic error – confusion between milligrams and micrograms, between milliliters and “units” on an insulin syringe, between mass concentration and molar concentration. It rarely costs the health of the sample and often the precision of the experiment – which […]

Mehr lesen
A woman is analyzing an HPLC certificate
How to read an HPLC certificate – a guide for researchers

The certificate of peptide analysis usually comes to you as a one-page PDF file or paper scan. At first glance – a few logos, a table with numbers, percentage of purity next to the HPLC heading, somewhere below the mass spectrum or its numerical representation. Most researchers only look at one number: purity. If they see “≥98%”, they consider it resolved and proceed to […]

Mehr lesen
peptide storage in the laboratory
Peptide storage – temperature, light and stability in laboratory practice

The most common misunderstanding when working with research peptides isn’t about reconstitution or dosing – it’s about storage. In the laboratory, you can find vials of BPC-157 left on the counter over the weekend, ampoules of TB-500 repeatedly frozen and thawed during the experiment, and semaglutide stored for a year in the refrigerator door next to the milk. Each of these cases is an error that will not be revealed […]

Mehr lesen
A woman demonstrates the weight-loss effects of yohimbine
Yohimbine – mechanism of action and research on the alpha-2 receptor antagonist

You’ve been training for months. You maintain your calorie deficit with surgical precision. The fat comes off the arms, chest, legs – but the lower belly and side folds stubbornly resist the granite wall. It’s not a matter of discipline or genetics in the common sense. It’s a receptor issue: fat cells in these “resistant” areas have more alpha-2 adrenergic receptors than the rest of the body. And […]

Mehr lesen
mk-677 vs fragment hgh
MK-677 vs HGH Fragment 176-191 – Comparison of Two Approaches to the Growth Hormone Axis

Two molecules. Two fundamentally different approaches to the same hormonal axis. MK-677 tells the pituitary gland to “produce more growth hormone.” HGH Fragment 176-191 tells fat tissue to “act as if you were getting growth hormone – without the rest of its effects.” One stimulates the endogenous production of the entire hormone. The second provides an isolated fragment responsible for one specific action. Which of these mechanisms […]

Mehr lesen
sr-9009 stenabolic
SR-9009 (Stenabolic) – Metabolism and Biological Clock Research

It’s 3 a.m. Your brain produces melatonin, your intestines slow down your peristalsis, your body temperature drops to a minimum. Every cell in the body “knows” that it is night – and behaves accordingly. This internal schedule is the biological clock: a network of feedbacks between clock genes that synchronizes metabolism, immunity, regeneration and sleep with the day-night cycle. What if […]

Mehr lesen

Six Knowledge Areas

Regenerative peptides and neuropeptides: molecular mechanisms

The broadest section of the catalog. It covers tissue-regeneration peptides (BPC-157, TB-500, GHK-Cu, PEG-MGF), neuropeptides (Semax, Selank, DSIP), and melanocortin peptides (PT-141, Melanotan II). Each article starts with the discovery context and then moves to the molecular mechanism: signaling pathways, target receptors, and pharmacokinetics.

SARMs ? selective androgen receptor modulators

A class of non-peptide compounds with high affinity for the androgen receptor, intensively studied in the context of anabolic clinical protocols. This section discusses pharmacological mechanisms, phase I and phase II clinical data, and comparisons of research profiles across individual compounds.

Laboratory practice ? reconstitution, storage, analysis

A procedural section. It explains how to correctly reconstitute a lyophilized reagent, which water to use, how to maintain solution stability in the cold chain, and how to interpret the analytical document attached to each batch. Materials for people running laboratory protocols.

Metabolism and incretins ? GLP-1 peptides

A section focused on one of the fastest-growing pharmacological classes of the 21st century: GLP-1 receptor agonists and their derivatives. It covers semaglutide (first generation, well established in clinical trials) and retatrutide (a GLP-1/GIP/glucagon tri-agonist, currently in phase III clinical trials).

Anti-aging and longevity ? peptides in aging research

The fifth area: peptides in the context of cellular aging processes, telomere regulation, neuroplasticity in later adulthood, and social-axis hormones (oxytocin). This section maintains methodological rigor ? highlighting that most evidence still comes from animal models or short-term human trials.

Quality, safety, and regulation

An analytical and regulatory section. It explains how HPLC and MS methods work, which standards apply to research-peptide suppliers in Europe, what to look for when evaluating a source, and what legal status research peptides have in the Polish regulatory system.